Gene · 23523
Papers2,301
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,301
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| At-Home Foscarnet Administration in Patients with Cytomegalovirus Infection Post-Allogeneic Stem Cell Transplantation: A Unicentric, Safe, and Feasible Program. | Pharmaceuticals (Basel) | 2023 | 38139867 | PubTator, text mining | PubMed |
| Adverse Drug Events after Kidney Transplantation. | J Pers Med | 2023 | 38138933 | PubTator, text mining | PubMed |
| Cell cycle arrest biomarkers for the early detection of acute allograft dysfunction and acute rejection in living donor kidney transplantation: a cross-sectional study from Egypt. | Korean J Transplant | 2023 | 38115166 | PubTator, text mining | PubMed |
| Measurement of the Immunosuppressant Possession Ratio by Transplant Clinical Pharmacists Captures a Non-Adherence Associated With Antibody-Mediated Rejection. | Transpl Int | 2023 | 38089004 | PubTator, text mining | PubMed |
| Targeting CaN/NFAT in Alzheimer's brain degeneration. | Front Immunol | 2023 | 38077352 | PubTator, text mining | PubMed |
| Management and treatment of children, young people and adults with systemic lupus erythematosus: British Society for Rheumatology guideline scope. | Rheumatol Adv Pract | 2023 | 38058676 | PubTator, text mining | PubMed |
| Focal Segmental Glomerulosclerosis: Assessing the Risk of Relapse. | Kidney Int Rep | 2023 | 38025232 | PubTator, text mining | PubMed |
| Humoral and Cellular Immunity Are Significantly Affected in Renal Transplant Recipients, following Vaccination with BNT162b2. | Vaccines (Basel) | 2023 | 38006002 | PubTator, text mining | PubMed |
| Kidney Transplant Recipients Show Limited Lung Diffusion Capacity but Similar Hydrogen Peroxide Exhalation as Healthy Matched Volunteers: A Pilot Study. | J Clin Med | 2023 | 38002579 | PubTator, text mining | PubMed |
| Proteomic analysis investigating kidney transplantation outcomes- a scoping review. | BMC Nephrol | 2023 | 37993798 | PubTator, text mining | PubMed |
| Activation-induced cytidine deaminase an antibody diversification enzyme interacts with chromatin modifier UBN1 in B-cells. | Sci Rep | 2023 | 37949972 | PubTator, text mining | PubMed |
| Moving toward a contemporary classification of drug-induced kidney disease. | Crit Care | 2023 | 37946280 | PubTator, text mining | PubMed |
| The Coexisting Neuromyelitis Optica Spectrum Disorder and Systemic Lupus Erythematosus: A Therapeutic Challenge. | Mediterr J Rheumatol | 2023 | 37941871 | PubTator, text mining | PubMed |
| Development of a predictive nomogram for switching immunosuppressive drugs in pediatric liver transplant recipients. | Front Pediatr | 2023 | 37928356 | PubTator, text mining | PubMed |
| Approach to Pregnancy in Patients With Lupus Nephritis. | Kidney Med | 2023 | 37915962 | PubTator, text mining | PubMed |
| Efficacy and safety of immunosuppressive agents for adults with lupus nephritis: a systematic review and network meta-analysis. | Front Immunol | 2023 | 37901212 | PubTator, text mining | PubMed |
| Immune Profile Determines Response to Vaccination against COVID-19 in Kidney Transplant Recipients. | Vaccines (Basel) | 2023 | 37896986 | PubTator, text mining | PubMed |
| Analyzing COVID-19 Vaccine Responses in Transplant Recipients. | Immunohorizons | 2023 | 37889158 | PubTator, text mining | PubMed |
| Chronic Lung Allograft Dysfunction Is Associated with Significant Disability after Lung Transplantation-A Burden of Disease Analysis in 1025 Cases. | Adv Respir Med | 2023 | 37887076 | PubTator, text mining | PubMed |
| Hottest topics in hematopoietic stem cell transplantation: a summary from the 8th International Transplant and Cellular Therapy Course. | Clin Hematol Int | 2023 | 37869470 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23523/papers?page=8